Health Care

AmCham Germany discusses current health care policies within two policy committees: the Health Care Committee and the Business of Healthcare Committee. The Health Care Committee focuses exclusively on issues of interest to pharmaceutical companies engaged in research, while the Business of Healthcare Committee takes a broader approach and represents the interests of the entire health care industry.

Both policy committees maintain a clear, constructive and open communication with various policy and decision-makers on the regional and federal level as well as on the European level depending on the issues. The development of the pharmaceutical and healthcare market, as well as the development and distribution of related information is closely monitored. The committees cooperate closely.

Health Care News

Health Care

Fresenius SE in the Series "Voices for TTIP" by AmCham Germany

"For consumers in Germany & across Europe TTIP means higher quality and lower prices. For companies, TTIP means easier access to other market...

Health Care

Stimmen zur Digitalisierung: Peter Albiez, Vorsitzender der Geschäftsführung, Pfizer Deutschland GmbH

"We have been working for some years now on the topic of digital communication. Now more than ever we are asking ourselves how digital solutions can...

Health Care

AmCham Germany Forum zu TTIP in der Gesundheitsbranche

Lilly-Geschäftsführerin Simone Thomsen: "Mehr über die Chancen eines TTIP-Abkommens reden"

Business of Healthcare Committee

The Business of Healthcare Committee represents the interests of all healthcare industries within AmCham Germany, ranging from pharmaceutical research companies to medical technology and diagnostics as well as IT firms and the consumer health sector.

Health Care Committee

AmCham Germany's Health Care Committee represents the interests of international pharmaceutical companies engaged in research in Germany.


Diskussionspapier "Big Data und E-Health: Erfahrungswerte aus der transatlantischen Gesundheitswirtschaft“

PDF 1.21 MB

Stellungnahme "Herausforderungen der Gesundheitsversorgung - Positionen der Gesundheitswirtschaft (April 2014)

PDF 92.68 KB

Stellungnahme zum Referentenentwurf "Gesetz zur Verbesserung der Versorgungsstrukturen in der gesetzlichen Krankenversicherung (GKV-VSG)" (August 2011)

PDF 887.19 KB

Prognose Spezialversorgung: Übersicht zur Entwicklung des Marktes der Spezialversorgung (PDF)

PDF 410.86 KB

Forecast Special Care Drugs: Development of the Market of Special Care Drugs (PDF)

PDF 405.00 KB